News

Eli Lilly and Company (LLY) Announces New Phase 3 Trial Results for Orforglipron

Eli Lilly and Company (NYSE:LLY) is one of the Stocks With Huge Catalysts on the Horizon. On July 21, Eli Lilly and Company ...

Lilly set for strong quarter after Novo profit warning

Investors and analysts say they expect Eli Lilly to report stronger quarterly sales and profit next week than Danish rival ...
WFYI3h

Senators raise questions about deals between telehealth and drug companies

Lawmakers warn the arrangement Eli Lilly and Pfizer have with telehealth platforms may lead to conflicts of interest, subpar ...

Eli Lilly’s stock drops as Trump targets 17 drug makers with letters on their pricing

Shares of Eli Lilly & Co. erased gains to trade down nearly 1% after White House press secretary Karoline Leavitt said the company was among 17 drugmakers that will be receiving letters from President ...

Lilly's cancer drug more effective than AbbVie's in head-to-head study

Eli Lilly said on Tuesday its drug for a type of blood cancer was more effective in a head-to-head study against AbbVie's ...

What's Going On With Eli Lilly Stock On Tuesday?

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...

Eli Lilly and Biogen/Eisai’s extension trials make waves in Alzheimer’s market

Lilly’s Kisunla and Biogen/Eisai’s Leqembi can both continue to slow Alzheimer's cognitive decline after more than three ...
PharmExec3d

Eli Lilly and Company Acquires Vere Therapeutics to Further Develop One-Time Cardiovascular Treatments

Eli Lilly's acquisition of Vere Therapeutics promises to revolutionize cardiovascular care with innovative one-time gene ...